Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION

Last updated on 2025-05-02 History
Report ID 255266
Drug Identification Number 02514095
Brand name DILTIAZEM HYDROCHLORIDE INJECTION
Common or Proper name DILTIAZEM HYDROCHLORIDE
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 5 mL vial / fiole
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-06-30
Actual start date
Estimated end date 2025-07-31
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-02
Company comments We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2025-05-02 French Compare
v6 2025-05-02 English Compare
v5 2025-04-22 English Compare
v4 2025-04-21 French Compare
v3 2025-04-21 English Compare
v2 2025-04-21 French Compare
v1 2025-04-21 English Compare

Showing 1 to 7 of 7